KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) Invested Capital (2016 - 2025)

Historic Invested Capital for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to $534.1 million.

  • Dynavax Technologies' Invested Capital fell 2161.48% to $534.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $534.1 million, marking a year-over-year decrease of 2161.48%. This contributed to the annual value of $596.8 million for FY2024, which is 406.27% down from last year.
  • As of Q3 2025, Dynavax Technologies' Invested Capital stood at $534.1 million, which was down 2161.48% from $494.2 million recorded in Q2 2025.
  • Dynavax Technologies' Invested Capital's 5-year high stood at $681.4 million during Q3 2024, with a 5-year trough of $67.6 million in Q3 2021.
  • For the 5-year period, Dynavax Technologies' Invested Capital averaged around $459.6 million, with its median value being $534.1 million (2025).
  • In the last 5 years, Dynavax Technologies' Invested Capital soared by 74372.46% in 2021 and then crashed by 2312.94% in 2025.
  • Over the past 5 years, Dynavax Technologies' Invested Capital (Quarter) stood at $222.4 million in 2021, then surged by 161.28% to $581.0 million in 2022, then grew by 7.07% to $622.1 million in 2023, then decreased by 4.06% to $596.8 million in 2024, then dropped by 10.5% to $534.1 million in 2025.
  • Its Invested Capital was $534.1 million in Q3 2025, compared to $494.2 million in Q2 2025 and $530.9 million in Q1 2025.